Fundraising FoxArrowhead Pharmaceuticals
1 known investors
Find your way into Arrowhead Pharmaceuticals
Sign up to see every warm intro you have to Arrowhead Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arrowhead Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Arrowhead Pharmaceuticals develops RNAi-based therapeutics using its targeted RNAi molecule (TRiM) platform, which silences disease-causing genes for conditions with significant unmet medical needs. It has multiple drug candidates in clinical trials across a range of disease areas.
Investors · 1
In the news
Frequently asked questions
- What does Arrowhead Pharmaceuticals do?
- Arrowhead Pharmaceuticals develops RNAi-based therapeutics using its targeted RNAi molecule (TRiM) platform, which silences disease-causing genes for conditions with significant unmet medical needs. It has multiple drug candidates in clinical trials across a range of disease areas.
- Who are Arrowhead Pharmaceuticals's investors?
- Arrowhead Pharmaceuticals's investors include Ridgeback Capital.